CD274 and esophageal squamous cell carcinoma: Okadome et al. (2020) reported that the recurrence and progression rates of PD‐L1–positive ESCC are higher than those of PD‐L1–negative ESCC, indicating that PD‐L1 expression promotes ESCC recurrence.